|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA
* To whom correspondence should be addressed. E-mail: WSTENSON{at}im.wustl.edu.
Lipopolysaccharide (LPS) is radioprotective in the mouse small intestine through a mechanism that includes the synthesis of cyclooxygenase-2 (Cox-2) and prostaglandin
(PGE2). The goal of this study was to identify the intermediate steps in this process. We used wild type (WT) C57BL/6 mice and knockouts for tumor necrosis factor receptors 1 and 2 (TNFR1 -/-, TNFR2-/-) and RAG-1 -/- mice. Mice were given parenteral LPS and then subjected to 12 Gy total body
-irradiation. The number of surviving intestinal crypts was assessed 3.5 days after irradiation using a clonogenic assay. Crypt cell apoptosis was assessed by histology. Parenteral administration of LPS induced Cox-2 expression, PGE2 production, and
radioprotection in WT and TNFR2-/- mice, but not in TNFR1-/- mice. TNFR1-/- mice were radioprotected by administration of exogenous dimethyl-PGE2. Immunohistochemical studies localized TNFR1 and Cox-2 expression to subeptihelial fibroblasts and villus epithelial cells.
Radiation-induced apoptosis was reduced by pretreatment with LPS in WT and TNFR2 -/- mice but not in TNFR1 -/- mice. In the absence of LPS, crypt survival was elevated in TNFR1 -/- when compared with WT mice. These findings demonstrate that TNFR1 function is required for LPS induced radioprotection in C57BL/6 mice, and defines an essential role for TNFR1 function in the induction of Cox-2 expression and PGE2 production in this process. The immunolocalization of TNFR1 and Cox-2 expression to subepithelial fibroblasts following LPS administration suggests that this cell type plays an intermediate role in LPS induced radioprotection in the intestine.
This article has been cited by other articles:
![]() |
K. L. W. Walton, L. Holt, and R. B. Sartor Lipopolysaccharide activates innate immune responses in murine intestinal myofibroblasts through multiple signaling pathways Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G601 - G611. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ramalingam, G. Natarajan, C. Schafer, D. Subramaniam, R. May, I. Ramachandran, L. Queimado, C. W. Houchen, and S. Anant Novel intestinal splice variants of RNA-binding protein CUGBP2: isoform-specific effects on mitotic catastrophe Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G971 - G981. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Riehl, R. J. George, M. A. Sturmoski, R. May, B. Dieckgraefe, S. Anant, and C. W. Houchen Azoxymethane protects intestinal stem cells and reduces crypt epithelial mitosis through a COX-1-dependent mechanism Am J Physiol Gastrointest Liver Physiol, December 1, 2006; 291(6): G1062 - G1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Murmu, J. Jung, D. Mukhopadhyay, C. W. Houchen, T. E. Riehl, W. F. Stenson, A. R. Morrison, T. Arumugam, B. K. Dieckgraefe, and S. Anant Dynamic antagonism between RNA-binding protein CUGBP2 and cyclooxygenase-2-mediated prostaglandin E2 in radiation damage PNAS, September 21, 2004; 101(38): 13873 - 13878. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |